Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747420 · ClinicalTrials.gov registry record · NA
PTNS Versus Sham Efficacy in Treatment of BPS
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02747420 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT02747420, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a prospective, single center, double-blind, randomized, controlled trial comparing the efficacy of percutaneous tibial nerve stimulation to sham in the treatment of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) through 12 weeks of therapy.
Interventions
- DEVICE Sham
- DEVICE NURO TM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747420
The ClinicalTrials.gov registry entry for NCT02747420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT02747420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02747420 about?
NCT02747420 is a clinical study titled "PTNS Versus Sham Efficacy in Treatment of BPS". This is a prospective, single center, double-blind, randomized, controlled trial comparing the efficacy of percutaneous tibial nerve stimulation to sham in the treatment of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) through 12 weeks of therapy.
What is the current status of trial NCT02747420?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-06. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02747420?
The interventions under investigation include: Sham (DEVICE), NURO TM (DEVICE).
Who is sponsoring clinical trial NCT02747420?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.